ALS-FTD Mouse Model Develops Motor Neuron Disease
November 11, 2016 - als
11 Nov 2016
In a Nov 9 Proceedings of a National Academy of Sciences, scientists led by Mervyn Monteiro, University of Maryland School of Medicine, Baltimore, report dual new models of amyotrophic parallel sclerosis/frontotemporal dementia. The researchers voiced mutant versions of a ubiquilin 2 gene in neurons of mice. The animals grown training deficits, as did other UBQLN2 models, though in addition, their engine neurons degenerated and aggregates of TDP-43 amassed in their spinal cords. These animals, that reproduce a TDP-43 pathology that underlies ALS/FTD improved than any other indication to date, competence assistance scientists know a links between UBQLN2 and proteostasis, as good as between TDP-43 pathology and engine neuron disease, pronounced Monteiro. Other researchers cautioned that a upholder used to overexpress UBQLN2 competence underlie a neurodegeneration, not UBQLN2 itself.
“This is a vital alleviation to existent rodent models of ALS-FTD,” wrote Mark Verheijen, University Medical Center Utrecht, The Netherlands, to Alzforum. “The anticipating directly relates a vital ALS illness pathway—impaired proteostasis—to a pivotal neuropathological underline in ALS,” namely TDP-43 pathology, he wrote. Verheijen was not concerned in the work.
Ubiquilin 2 binds proteins tagged with ubiquitin and shuttles them to a proteasome for ordering (for a review, see Lee and Brown, 2012). This routine is essential for clearing protein aggregates (Brown and Kaganovitch, 2016). Ubiquilin 2 also helps broach autophagosomes to lysosomes, that reduce neglected proteins (N’Diaye et al., 2009; Rothenberg et al., 2010). In 2011, researchers related variants in a UBQLN2 gene with patrimonial ALS/FTD (Deng et al., 2011). Since then, UBQLN2 mutations have been identified in occasionally ALS and FTD, accounting for an estimated 1 to 2 percent of cases, respectively (Synofzik et al., 2012). Patients who lift a singular duplicate of a deteriorated gene amass ubiquilin 2-positive inclusions in neurons of a hippocampus, and TDP-43 aggregates in engine neurons in a spinal cord. The illness variants are mostly missense mutations that combine around a segment coding for a protein’s executive domain (Williams et al., 2012).
To examine how UBQLN2 mutations lead to ALS and FTD, researchers have generated several rodent and rodent models that overexpress a deteriorated tellurian gene. Some of a animals rise cognitive deficits, ubiquilin inclusions, and neuron detriment in a mind (Wu et al., 2015; Gorrie et al., 2014), though so far, nothing have engine neuron disease. One aria performs feeble on a rotarod exam and clasps a paws some-more than normal animals, both signs of intensity engine neuron problems, though a physiological reason for these behaviors is misleading (Ceballos-Diaz et al., 2015). Monteiro and colleagues directed to emanate a UBQLN2 rodent indication that some-more entirely mirrored human disease.
First authors Nhat Le, Lydia Chang, and Irina Kovlyagina used a neuron-specific Thy1.2 countenance cassette to furnish a P497S, P506T, or wild-type variants of UBQLN2 in a rodent mind and spinal cord. Mice voiced their possess form of a protein, and about 70 to 80 percent some-more of a tellurian versions. Both a P497S and P506T variants have been related to ALS/FTD.
Le and colleagues weighed a mice and totalled their engine functions biweekly from dual to 8 months of age. Those that voiced a P497S or P506T variants gained weight routinely until 18 and 26 weeks, respectively, afterwards fell behind. At a finish of a study, they were about 30 percent lighter than control mice expressing a normal transgene. At 6 weeks, a P506T mice began to remove hold strength and could not hang onto a rotating rod as prolonged as did controls. For P497S mice this started during 12 weeks. Both strains also clasped their paws more, and in some animals a rear limbs became paralyzed.
At dual and 4 months, a researchers tested training and memory in a animals regulating a novel-object-recognition charge and a Y-maze. Like controls, two- and four-month-old mutant UBQLN2 carriers elite to try down a novel arm of a Y-maze, suggesting normal training and memory. However, during 4 months, a mice had difficulty specifying between novel and informed objects placed in a contrast arena, suggesting their memory was impaired. It is misleading if these problems wear as a mice age given comparison animals were too diseased to test.
Mice overexpressing a mutant UBQLN2 died young, during an normal 246 days for a P506T line and 305 for a P497S mice. Animals that voiced a wild-type transgene outlived a 500-day examine though motor difficulties.
In postmortem analysis, a researchers found an age-dependent buildup of UBQLN inclusions in neurons of a brain. These inclusions populated layers V and VI of a cortex, tools of a dentate gyrus, CA1 segment of a hippocampus, brainstem, and striatum. The settlement resembled that seen in other UBQLN2 rodent models and in ALS/FTD patients with UBQLN2 mutations, a authors wrote. Inclusions tested certain for ubiquitin and Thioflavin S.
The authors afterwards tested for TDP-43 in a engine neurons of a spinal cord. Similar to what is seen in humans, a protein vacated a iota to form granular inclusions in a cytoplasm, that also contained ubiquilin 2 (see picture above). Mice that voiced no transgene, or a wild-type chronicle of tellurian UBQLN2, had no TDP-43 pathology and few ubiquilin 2 inclusions, that according to Monteiro can form as normal animals age. Researchers detect TDP-43 pathology in 97 percent of tellurian ALS cases though not in a SOD1 rodent models that are ordinarily used in ALS research. Some models have TDP-43 inclusions though keep many of a protein in a nucleus, Monteiro added. “Because chief clearway could be mechanistically related to ALS pathogenesis, recapitulating this materialisation in models is important,” he suggested.
The researchers afterwards compared postmortem hankie samples of three- and eight-month-old animals. Older P506T and P497S mice had fewer engine neurons in a ventral horn of a spinal cord and in a CA1 and dentate gyrus of a hippocampus. They sported smaller calf muscles, thinner flesh fibers, and fewer large-caliber axons, suggesting flesh wasting and degeneration. Synaptophysin and α-bungarotoxin co-stained reduction mostly during a neuromuscular junctions, suggesting reduced innervation. Taken together, a formula indicate to engine neuron illness in these animals.
Monteiro is uncertain since engine neurons trouble-maker in these though not other UBQLN2 models. He suggested that a levels of protein countenance in other models were reduce since they used a CamK2α or a endogenous murine UBQLN2 promoter. Alternatively, it could be since a informal countenance of a transgene was some-more limited to a brain, he said. Along those lines, Manuela Neumann, University of Tübingen, Germany, cautioned that a Thy1.2 upholder leads to abnormally high countenance of transgenes in a spinal cord, that could lead to engine problems eccentric of a mutations themselves. “As always, one has to be really discreet with interpreting formula from overexpression models, quite those with ectopic expression,” she said. Teepu Siddique, Northwestern University, Chicago, echoed a concern, observant that engine stoppage or debility can be prompted by expressing genes separate to ALS regulating a Thy1.2 upholder (Götz et al., 2000). Monteiro forked out that control mice voiced wild-type UBQLN2 driven by a Thy1.2 promoter, nonetheless did not rise engine neuron disease.
Neumann found it engaging that UBQLN2 overexpression seemed to kill cells even in regions that lacked TDP-43 pathology, such as a hippocampus. This anticipating jibes with other UBQLN2 models where dungeon genocide occurs in a deficiency of TDP-43 pathology. “This suggests that TDP-43 assembly per se competence not be a essential step mediating dungeon genocide in ALS/FTD cases with UBQLN2 mutations,” said Neumann.
Other scientists suspicion a mice could be illuminating. “These UBQLN2 mutant mice can assistance researchers examine a accurate time march of, and tie between, histopathological facilities [of ALS/FTD], such as UBQLN2 inclusion formation, TDP43 pathology, flesh denervation, neuronal dungeon loss, and gliosis,” wrote Gregor Bieri, Stanford University School of Medicine in California. “Further, they could be used privately to exam intensity healing interventions that aim UBQLN2 countenance or accumulation,” he said.
Verheijen would like to know if RNA estimate and ride is altered in these mice. After all, both have been related to ALS/FTD by RNA-binding proteins such as TDP43 and FUS, and poisonous RNA class generated from expansions in a C9ORF72 gene. Monteiro skeleton to make a mice available, presumably by a Jackson Laboratory in Bar Harbor, Maine.—Gwyneth Dickey Zakaib
Lee DY, Brown EJ.
Ubiquilins in a crosstalk among proteolytic pathways.
Biol Chem. 2012 May;393(6):441-7.
Brown R, Kaganovich D.
Look Out Autophagy, Ubiquilin UPS Its Game.
Cell. 2016 Aug 11;166(4):797-9.
N’Diaye EN, Kajihara KK, Hsieh I, Morisaki H, Debnath J, Brown EJ.
PLIC proteins or ubiquilins umpire autophagy-dependent dungeon presence during nutritious starvation.
EMBO Rep. 2009 Feb;10(2):173-9. Epub 2009 Jan 16
Rothenberg C, Srinivasan D, Mah L, Kaushik S, Peterhoff CM, Ugolino J, Fang S, Cuervo AM, Nixon RA, Monteiro MJ.
Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.
Hum Mol Genet. 2010 Aug 15;19(16):3219-32.
Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, Jiang H, Hirano M, Rampersaud E, Jansen GH, Donkervoort S, Bigio EH, Brooks BR, Ajroud K, Sufit RL, Haines JL, Mugnaini E, Pericak-Vance MA, Siddique T.
Mutations in UBQLN2 means widespread X-linked youthful and adult-onset ALS and ALS/dementia.
Nature. 2011 Sep 8;477(7363):211-5.
Synofzik M, Maetzler W, Grehl T, Prudlo J, Vom Hagen JM, Haack T, Rebassoo P, Munz M, Schöls L, Biskup S.
Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outward a PXX domain and a pristine FTD phenotype.
Neurobiol Aging. 2012 Dec;33(12):2949.e13-7.
Williams KL, Warraich ST, Yang S, Solski JA, Fernando R, Rouleau GA, Nicholson GA, Blair IP.
UBQLN2/ubiquilin 2 turn and pathology in patrimonial amyotrophic parallel sclerosis.
Neurobiol Aging. 2012 Oct;33(10):2527.e3-2527.e10.
Wu Q, Liu M, Huang C, Liu X, Huang B, Li N, Zhou H, Xia XG.
Pathogenic Ubqln2 gains poisonous properties to satisfy neuron death.
Acta Neuropathol. 2015 Mar;129(3):417-28. Epub 2014 Nov 12
Gorrie GH, Fecto F, Radzicki D, Weiss C, Shi Y, Dong H, Zhai H, Fu R, Liu E, Li S, Arrat H, Bigio EH, Disterhoft JF, Martina M, Mugnaini E, Siddique T, Deng HX.
Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2.
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14524-9. Epub 2014 Sep 22
Ceballos-Diaz C, Rosario AM, Park HJ, Chakrabarty P, Sacino A, Cruz PE, Siemienski Z, Lara N, Moran C, Ravelo N, Golde TE, McFarland NR.
Viral countenance of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
Mol Neurodegener. 2015 Jul 8;10:25.
Götz J, Barmettler R, Ferrari A, Goedert M, Probst A, Nitsch RM.
In vivo examine of wild-type and FTDP-17 tau transgenic mice.
Ann N Y Acad Sci. 2000;920:126-33.